The Drug Controller General of India has issued a cautionary advisory to doctors and healthcare professionals regarding the discontinuation of Digene gel in the event of adverse drug reactions. This follows a complaint received by the DCGI about a batch of Digene gel produced by Abbott India in Goa, which had unusual characteristics.
India News: The Drug Controller General of India (DCGI) has advised doctors and healthcare professionals to educate their patients to discontinue the use of Digen
Technical flaws at pharma units invited ire of regulatory bodies tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.
209 pharma units under govt lens over violations, 71 in Himachal Pradesh tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.